Alison Zinsli, M.S.P.H., joined Statistics Collaborative, Inc. (SCI) in 2018.

At SCI, Ms. Zinsli has worked with clinical trials assessing treatments in a variety of disease areas, including myocardial infarction, neovascular age-related macular degeneration, Huntington’s disease, adolescent weight management, and several types of cancer. As a biostatistician, she performs statistical analyses, programs datasets, generates graphs, tables and listings, and validates program code for DMC, futility and PK/PD reports.

Prior to joining SCI, Ms. Zinsli worked at the Emory University School of Medicine in the Human Genetics Department focusing on galactosemia. She completed her master’s practicum at the Emory University Hospital in the Department of Urology where she investigated the relationship between monocyte-lymphocyte ratios and high-risk renal cell carcinoma survival.

She received her B.S. magna cum laude in Mathematical Statistics with minors in Computer Science and Biology from Wake Forest University (2016) and her M.S.P.H. in Biostatistics from the Rollins School of Public Health at Emory University (2018). Her master’s thesis was titled “Evaluation of agreement measures among groups of raters with an application to the interpretation of kidney obstruction”.